Spots Global Cancer Trial Database for advanced malignant pleural mesothelioma
Every month we try and update this database with for advanced malignant pleural mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma | NCT04166734 | Advanced Malign... | Pembrolizumab Stereotactic Bo... | 18 Years - | Royal Marsden NHS Foundation Trust | |
A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy | NCT01769547 | Advanced Malign... MPM | Dovitinib | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) | NCT00128102 | Mesothelioma Lung Cancer | Vorinostat Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM | NCT01358084 | Advanced Malign... | NGR-hTNF Placebo Best Supportive... | 18 Years - | AGC Biologics S.p.A. |